NRX Pharmaceuticals (NRXP) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for NRX Pharmaceuticals (NRXP) stock.

Latest Upgrades and Downgrades for NRX Pharmaceuticals Stock

Date	Firm	Analyst	Action	Rating Change	Price Target
—	Ascendiant Capital	Edward Woo	PT Raise	Buy	$50→$51
—	Ascendiant Capital	Edward Woo	PT Raise	Buy	$49→$50
—	BTIG	Thomas Shrader	Maintained	Buy	$10
—	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$45
—	BTIG	Thomas Shrader	Maintained	Buy	$10
—	BTIG	Thomas Shrader	PT Cut	Buy	$25→$10
—	D. Boral Capital	Jason Kolbert	Maintained	Buy	$34
—	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$45
—	Ascendiant Capital	Edward Woo	PT Raise	Buy	$48→$49
—	D. Boral Capital	Jason Kolbert	Maintained	Buy	$34
—	D. Boral Capital	Jason Kolbert	Maintained	Buy	$34
—	D. Boral Capital	Jason Kolbert	Maintained	Buy	$34
—	BTIG	Thomas Shrader	Maintained	Buy	$25
—	D. Boral Capital	Jason Kolbert	Maintained	Buy	$34
—	D. Boral Capital	Jason Kolbert	Maintained	Buy	$34
—	D. Boral Capital	Jason Kolbert	Maintained	Buy	$34
—	HC Wainwright & Co.	Patrick R. Trucchio	PT Raise	Buy	$40→$45
—	BTIG	Thomas Shrader	Maintained	Buy	$25
—	D. Boral Capital	Jason Kolbert	Maintained	Buy	$34
—	BTIG	Thomas Shrader	Maintained	Buy	$25

Analyst Ratings News

Regeneron Pharmaceuticals To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Monday

Analysts upgraded MHK and CRWD, downgraded PFSI, cut ABOS’s target, and raised targets for NRXP, REGN and NTSK.

Avi Kapoor

PRO
Ascendiant Capital Maintains Buy on NRX Pharmaceuticals, Raises Price Target to $51

Ascendiant Capital analyst Edward Woo maintains NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy and raises the price target from $50 to $51.

Benzinga Newsdesk

PRO
Ascendiant Capital Maintains Buy on NRX Pharmaceuticals, Raises Price Target to $50

Ascendiant Capital analyst Edward Woo maintains NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy and raises the price target from $49 to $50.

Benzinga Newsdesk

PRO
BTIG Reiterates Buy on NRX Pharmaceuticals, Maintains $10 Price Target

BTIG analyst Thomas Shrader reiterates NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy and maintains $10 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on NRX Pharmaceuticals, Maintains $45 Price Target

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy and maintains $45 price target.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on NRX Pharmaceuticals, Lowers Price Target to $10

BTIG analyst Thomas Shrader maintains NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy and lowers the price target from $25 to $10.

Benzinga Newsdesk

NRX Pharmaceuticals Inc

NRX Pharmaceuticals (NRXP) Stock Price Target 2026

Latest Upgrades and Downgrades for NRX Pharmaceuticals Stock

NRX Pharmaceuticals (NRXP) Stock Price Target 2026

Latest Upgrades and Downgrades for NRX Pharmaceuticals Stock

Analyst Ratings News

Regeneron Pharmaceuticals To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Monday

PRO
Ascendiant Capital Maintains Buy on NRX Pharmaceuticals, Raises Price Target to $51

PRO
Ascendiant Capital Maintains Buy on NRX Pharmaceuticals, Raises Price Target to $50

PRO
BTIG Reiterates Buy on NRX Pharmaceuticals, Maintains $10 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on NRX Pharmaceuticals, Maintains $45 Price Target

PRO
BTIG Maintains Buy on NRX Pharmaceuticals, Lowers Price Target to $10

People Also Watch

People Also Watch

Analyst Ratings News

Regeneron Pharmaceuticals To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Monday

PRO
Ascendiant Capital Maintains Buy on NRX Pharmaceuticals, Raises Price Target to $51

PRO
Ascendiant Capital Maintains Buy on NRX Pharmaceuticals, Raises Price Target to $50

PRO
BTIG Reiterates Buy on NRX Pharmaceuticals, Maintains $10 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on NRX Pharmaceuticals, Maintains $45 Price Target

PRO
BTIG Maintains Buy on NRX Pharmaceuticals, Lowers Price Target to $10

NRX Pharmaceuticals Inc

NRX Pharmaceuticals (NRXP) Stock Price Target 2026

Latest Upgrades and Downgrades for NRX Pharmaceuticals Stock

NRX Pharmaceuticals (NRXP) Stock Price Target 2026

Latest Upgrades and Downgrades for NRX Pharmaceuticals Stock

Analyst Ratings News

Regeneron Pharmaceuticals To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Monday

PROAscendiant Capital Maintains Buy on NRX Pharmaceuticals, Raises Price Target to $51

PROAscendiant Capital Maintains Buy on NRX Pharmaceuticals, Raises Price Target to $50

PROBTIG Reiterates Buy on NRX Pharmaceuticals, Maintains $10 Price Target

PROHC Wainwright & Co. Reiterates Buy on NRX Pharmaceuticals, Maintains $45 Price Target

PROBTIG Maintains Buy on NRX Pharmaceuticals, Lowers Price Target to $10

People Also Watch

People Also Watch

Analyst Ratings News

Regeneron Pharmaceuticals To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Monday

PROAscendiant Capital Maintains Buy on NRX Pharmaceuticals, Raises Price Target to $51

PROAscendiant Capital Maintains Buy on NRX Pharmaceuticals, Raises Price Target to $50

PROBTIG Reiterates Buy on NRX Pharmaceuticals, Maintains $10 Price Target

PROHC Wainwright & Co. Reiterates Buy on NRX Pharmaceuticals, Maintains $45 Price Target

PROBTIG Maintains Buy on NRX Pharmaceuticals, Lowers Price Target to $10

PRO
Ascendiant Capital Maintains Buy on NRX Pharmaceuticals, Raises Price Target to $51

PRO
Ascendiant Capital Maintains Buy on NRX Pharmaceuticals, Raises Price Target to $50

PRO
BTIG Reiterates Buy on NRX Pharmaceuticals, Maintains $10 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on NRX Pharmaceuticals, Maintains $45 Price Target

PRO
BTIG Maintains Buy on NRX Pharmaceuticals, Lowers Price Target to $10

PRO
Ascendiant Capital Maintains Buy on NRX Pharmaceuticals, Raises Price Target to $51

PRO
Ascendiant Capital Maintains Buy on NRX Pharmaceuticals, Raises Price Target to $50

PRO
BTIG Reiterates Buy on NRX Pharmaceuticals, Maintains $10 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on NRX Pharmaceuticals, Maintains $45 Price Target

PRO
BTIG Maintains Buy on NRX Pharmaceuticals, Lowers Price Target to $10